학술논문
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype
Document Type
Article
Author
Source
In The Journal of Allergy and Clinical Immunology: In Practice November 2022 10(11):2916-2924
Subject
Language
ISSN
2213-2198